Immediate Impact
60 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
Works of G Mechkov being referenced
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis†
2009
Randomized, Double-Blind Study of Emtricitabine (FTC) plus Clevudine versus FTC Alone in Treatment of Chronic Hepatitis B
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G Mechkov | 240 | 108 | 57 | 161 | 12 | 333 | |
| Joel Martínez-Ocaña | 263 | 247 | 27 | 147 | 17 | 369 | |
| Anne Dao | 109 | 156 | 99 | 108 | 10 | 273 | |
| Conan Chow | 175 | 191 | 102 | 100 | 10 | 341 | |
| G. Nelson | 232 | 211 | 3 | 122 | 8 | 370 | |
| Chi-Ling Fu | 39 | 190 | 22 | 27 | 9 | 294 | |
| Valentin Yermakov | 29 | 55 | 38 | 89 | 14 | 317 | |
| Kamal Dumaidi | 35 | 39 | 146 | 32 | 19 | 283 | |
| Jia Shen | 29 | 185 | 36 | 47 | 19 | 314 | |
| S. A. Muhtaseb | 74 | 64 | 92 | 101 | 9 | 292 | |
| А.M. Abdybekova | 226 | 123 | 8 | 189 | 16 | 297 |
All Works
Loading papers...